215 filings
Page 5 of 11
UPLOAD
8w79xfzyzrb77ot
29 Sep 20
Letter from SEC
12:00am
8-K
0h4lw eljp7p6
13 Aug 20
Novocure Announces Expansion of its Executive Leadership Team
8:45am
8-K
mc77za
6 Aug 20
Termination of a Material Definitive Agreement
4:09pm
8-K
9ovekixnym9a53q
30 Jul 20
Novocure Reports Second Quarter 2020 Financial Results and Provides Company Update
8:11am
8-K
ow2vmhfbc17jy
15 Jul 20
Regulation FD Disclosure
10:38am
8-K
ntr1so
12 Jun 20
Departure of Directors or Certain Officers
4:10pm
8-K
ml8qzfat
13 May 20
China NMPA Approves OptuneĀ® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
10:19am
8-K
3dze6ti5h7
30 Apr 20
Novocure Reports First Quarter 2020 Financial Results and Provides Company Update
6:13am
DEFA14A
jcl2xnb1qjnoy
27 Apr 20
Additional proxy soliciting materials
4:45pm
8-K
hzp newapahl3ge28v
24 Apr 20
Departure of Directors or Certain Officers
5:19pm
8-K
8nd9kps 6efx3b9rlsa
6 Mar 20
Departure of Directors or Certain Officers
4:19pm
S-8
roep 82eoiv
3 Mar 20
Registration of securities for employees
4:05pm
8-K
e9e sj6b3
27 Feb 20
Novocure Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Company Update
6:07am
8-K
fet7ch iwwe
13 Jan 20
Novocure Announces Fourth Quarter and Full Year 2019 Preliminary Net Revenues and Provides Company Update
7:25am